Blueprint Medicine Gains US Approval For First Drug, Precision Medicine Ayvakit

Targets Mutation In GIST tumors

 
• By Andrew McConaghie
  
Blueprint_Medicines_Logo
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip